A federal appeals court had signed off on a deal that would shield members of the wealthy Sackler family from lawsuits in exchange for billions for those harmed by the opioid epidemic.
Category: Purdue Pharma
-
Fate of Billions for Opioid Victims From Sacklers Rests With Supreme Court
The court will decide whether Purdue’s owners can gain permanent immunity from future opioid lawsuits in exchange for payments up to $6 billion.
-
What the Supreme Court’s Decision to Hear the Purdue Pharma Case Means
A federal appeals court had signed off on a deal that would shield members of the wealthy Sackler family from lawsuits in exchange for billions for those harmed by the opioid epidemic.
-
Supreme Court Pauses Purdue Pharma Bankruptcy Deal
A federal appeals court had signed off on an agreement, now on hold, that would shield members of the wealthy Sackler family from opioid-related lawsuits in exchange for $6 billion for victims.
-
An Appeals Court Gave the Sacklers Legal Immunity. Here’s What the Ruling Means.
In return for the shield, the billionaire owners of Purdue Pharma are committed to paying up to $6 billion to help compensate communities and individuals for the ravages of the opioid epidemic.
-
Sacklers Can Be Shielded From Opioid Liability, Appeals Court Rules
The decision gives the Purdue Pharma owners long-sought protection, but it will release billions of dollars from their fortune to states and communities to help cope with the costs of addiction.
-
National Academies Members Demand Answers About Sacklers’ Donations
The Academies accepted millions of dollars from members of the Sackler family — including some who led Purdue Pharma, makers of OxyContin — even while advising federal officials on opioid policy.
-
Sacklers Gave Millions to Institution That Advises on Opioid Policy
Even as the nation’s drug crisis mounted, the National Academies of Sciences, Engineering and Medicine continued to accept funds from some members of the Sackler family, including those involved with Purdue Pharma.
-
‘All the Beauty and the Bloodshed’ Review: Nan Goldin’s Art and Activism
The New York Times – Movies:A new documentary focuses on the photographer’s struggle with OxyContin and her protest against the art establishment that took money from its makers.